Development, Inhibitex, Inc.
4. Diabetes Treatment: Advances in Cell-Based Therapies (June 17, 8:15
a.m. to 9:45 a.m., Room 29 CD)
a. Collin J. Weber, MD -- Chair, Professor of Surgery, Emory
University School of Medicine.
5. Improved Pharmaceutical Manufacturing Through Controlled Enzyme
Evolution (June 19, 4 p.m. to 5:30 p.m., Room 28 AB)
a. Andreas Bommarius, PhD -- Chair, Professor, School of Chemical &
Biomolecular Engineering, Georgia Institute of Technology.
About Georgia's Bioscience Industry
With strong talent, a spirit of collaboration and access to the world, Georgia is at the crossroads of global health. Georgia is home to the CDC, CARE, the American Cancer Society, the Arthritis Foundation and 270 bioscience companies. The state offers robust public-private partnerships in bioscience, including the Georgia Research Alliance, through which the State's six research universities collaborate to create, improve and grow science -- and technology-based companies. Additionally, Georgia boasts a strong talent pool, with the nation's highest growth in market share of college-educated 25-to-34 year-olds and one of the largest state university systems in the country, graduating 44,000 students each year. For more information on Georgia's bioscience industry and its presence at BIO 2008 and 2009, visit http://www.georgiabiosciences.com .
|SOURCE Georgia Department of Economic Development|
Copyright©2008 PR Newswire.
All rights reserved